Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             174 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal humoral immune response to mucosal antigenic stimulation in patients with lung cancer 1993
8 5-6 p. 334-
1 p.
artikel
2 A case-control study of malignant and non-malignant respiratory disease among employees of a fibreglass manufacturing facility 1993
8 5-6 p. 331-
1 p.
artikel
3 Accelerated CDE chemotherapy with GM-CSF in small cell lung cancer (SCLC) patients: A phase II study Ardizzoni, A.
1993
8 5-6 p. 356-
1 p.
artikel
4 Accuracy of the bronchoscopic DNA content analysis of non-small-cell lung carcinoma Haneda, H
1993
8 5-6 p. 343-344
2 p.
artikel
5 A combination of 60 mg/m2 cisplatin (CDDP) and 200 mg/m2 carboplatin (CBDCA) is as active but less nephrotoxic than 120 mg/m2 CDDP in patients with advanced non-small cell lung cancer (NSCLC) Giner, V.
1993
8 5-6 p. 354-
1 p.
artikel
6 A comprehensive evaluation of serum ferritin levels in lung cancer patients 1993
8 5-6 p. 343-
1 p.
artikel
7 Adjuvant treatment using transfer factor for bronchogenic carcinoma: Long-term follow-up 1993
8 5-6 p. 350-
1 p.
artikel
8 A gene from human chromosome region 3p21 with reduced expression in small cell lung cancer 1993
8 5-6 p. 333-
1 p.
artikel
9 Allelotype of non-small cell lung carcinoma - Comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma 1993
8 5-6 p. 337-
1 p.
artikel
10 Alternative splicing of neural-cell-adhesion molecule mRNA in human small-cell lung-cancer cell line H69 Moolenaarr, CEC
1993
8 5-6 p. 338-
1 p.
artikel
11 Amplification and rearrangement of L-myc in human small-cell lung cancer 1993
8 5-6 p. 333-
1 p.
artikel
12 Analysis of K-ras gene mutations in resectable non-small cell lung cancer (NSCLC) by polymerase chain reaction (PCR) and oligodeoxynucleotide hybridization Skacel, Z.
1993
8 5-6 p. 354-
1 p.
artikel
13 Announcements 1993
8 5-6 p. 323-324
2 p.
artikel
14 A phase III randomized study comparing weekly multiple drug chemotherapy versus standard combination for small cell lung cancer Sculier, J.P.
1993
8 5-6 p. 357-
1 p.
artikel
15 A phase II study of high dose epirubicin in unresectable non small cell lung cancer 1993
8 5-6 p. 345-
1 p.
artikel
16 A pilot study of intensive weekly chemotherapy for extensive disease small-cell lung carcinoma 1993
8 5-6 p. 345-
1 p.
artikel
17 Application of molecular genetics to the early diagnosis and screening of lung cancer 1993
8 5-6 p. 337-
1 p.
artikel
18 Aspects and results in the staging of lung cancer Bützebruck, H.
1993
8 5-6 p. 354-
1 p.
artikel
19 A 50-year projection of lung cancer deaths among Japanese males and potential impact evaluation of anti-smoking measures and screening using a computerized simulation model 1993
8 5-6 p. 329-
1 p.
artikel
20 Body mass index and lung cancer risk 1993
8 5-6 p. 330-
1 p.
artikel
21 Brain metastases from lung cancer: Results of radiotherapy and prognostic factors Nieder, C.
1993
8 5-6 p. 358-
1 p.
artikel
22 Brain metastases from small cell lung cancer: Response to chemotherapy in untreated patients żuławski, M.
1993
8 5-6 p. 357-
1 p.
artikel
23 British medical research council (MRC) randomised trials of palliative radiotherapy (RT) in the treatment of patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status Girling, David J.
1993
8 5-6 p. 355-
1 p.
artikel
24 Bronchoalveolar lavage in lung cancer 1993
8 5-6 p. 340-341
2 p.
artikel
25 Bronchoalveolar lavage in the assessment of primary and metastic lung cancer 1993
8 5-6 p. 341-
1 p.
artikel
26 Bronchogenic carcinoma in patients with pulmonary histiocytosis X Sadoun, D
1993
8 5-6 p. 341-
1 p.
artikel
27 Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples 1993
8 5-6 p. 347-
1 p.
artikel
28 Calendar 1993
8 5-6 p. 325-326
2 p.
artikel
29 Carbohydrate profiles shown by a lectin and a monoclonal antibody correlate with metastic potential and prognosis of human lung carcinomas 1993
8 5-6 p. 335-
1 p.
artikel
30 Carboplatin and vindesine in advanced non-small cell lung cancer. A feasibility study 1993
8 5-6 p. 346-
1 p.
artikel
31 Cardiac metastasis of lung cancer: A study of metastatic pathways and clinical manifestations 1993
8 5-6 p. 342-343
2 p.
artikel
32 Cell interactions and motility in human lung tumor cell lines HS-24 and SB-3 under the influence of extracellular matrix components and proteinase inhibitors 1993
8 5-6 p. 333-
1 p.
artikel
33 Chemoprevention strategies for lung and upper aerodigestive tract cancer 1993
8 5-6 p. 327-
1 p.
artikel
34 Chemotherapy with carboplatin/etoposide/vincristin (CEV) in patients with lung cancer and CNS-Metastases Hechmayr, M.
1993
8 5-6 p. 357-
1 p.
artikel
35 Chronic oral etopisode in non-small cell lung carcinoma 1993
8 5-6 p. 347-
1 p.
artikel
36 Cigarette smoke inhibits cytosolic but not microsomal epoxide hydrolase of human lung 1993
8 5-6 p. 328-
1 p.
artikel
37 Clinical significance of ras oncogene activation in human lung cancer 1993
8 5-6 p. 338-
1 p.
artikel
38 Clinical significance of tumor necrosis factor in patients with bronchogenic carcinoma and benign lung diseases: A comparative study Rapellino, M
1993
8 5-6 p. 342-
1 p.
artikel
39 Cloning of 67-kDa laminin receptor cDNA and gene expression in normal and malignant cell lines of the human lung Satoh, K
1993
8 5-6 p. 335-336
2 p.
artikel
40 Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer 1993
8 5-6 p. 346-
1 p.
artikel
41 Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma 1993
8 5-6 p. 345-
1 p.
artikel
42 Combined high dose rate endoluminal irradiation (AL) and external irradiation versus external irradiation alone in patients with central lung tumors - preliminary results of a randomized study Huber, R.M.
1993
8 5-6 p. 356-
1 p.
artikel
43 Completion pneumonectomy after bronchial sleeve resection: Incidence, indications, and results 1993
8 5-6 p. 344-
1 p.
artikel
44 Concurrent VP-16 + DDP and twice daily radiotherapy for limited small cell lung cancer: A pilot study Lewinski, T.
1993
8 5-6 p. 358-
1 p.
artikel
45 Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma 1993
8 5-6 p. 339-340
2 p.
artikel
46 Correlation of circulating antineuronal antibodies (CANA) with paraneoplastic syndromes in lung cancer Drlicek, Marcus
1993
8 5-6 p. 245-257
13 p.
artikel
47 Cyclophosphamide, epirubicin and etoposide (CEE) in small cell lung cancer (SCLC) Jassem, J.
1993
8 5-6 p. 356-
1 p.
artikel
48 Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines 1993
8 5-6 p. 337-
1 p.
artikel
49 Detection of a novel marker in the bronchial secretions of patients with non-small cell lung cancer using the 4B5 monoclonal antibody 1993
8 5-6 p. 340-
1 p.
artikel
50 Development of lung cancer mortality: Comparison between Czechoslovakia and Austria 1993
8 5-6 p. 329-
1 p.
artikel
51 Dietary determinants of lung-cancer risk: Results from a case-control study in Yunnan Province, China 1993
8 5-6 p. 328-
1 p.
artikel
52 Dietary factors in lung cancer prognosis 1993
8 5-6 p. 328-
1 p.
artikel
53 Different sequences of chemo- and radiotherapy in non-resectable non-small cell lung cancer (NSCLC). Five years experience Pes̆ek, M.
1993
8 5-6 p. 356-
1 p.
artikel
54 DNA analysis of malignant effusions: Comparison with cytologic diagnosis and carcinoembryonic antigen content 1993
8 5-6 p. 341-
1 p.
artikel
55 Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis 1993
8 5-6 p. 349-
1 p.
artikel
56 Dose intensity of initial chemotherapy may have an impact on survival in limited small cell lung carcinoma de Vathaire, F.
1993
8 5-6 p. 301-308
8 p.
artikel
57 Ecologic study of lung cancer risk factors in the U.S. and Japan, with special reference to smoking and diet 1993
8 5-6 p. 332-
1 p.
artikel
58 Effect of radio- and chemotherapy on indomethacin modulation of lymphoproliferative response in vitro of lung cancer patients Stanojević-Bakić, Nevenka
1993
8 5-6 p. 309-317
9 p.
artikel
59 Efficacy of lung cancer screening; Comparison of results from a case-control study and a survival analysis 1993
8 5-6 p. 332-
1 p.
artikel
60 Endobrochial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma 1993
8 5-6 p. 348-349
2 p.
artikel
61 Endobronchial chemotherapy (ECH) in combined non small cell lung cancer (NSCLC) treatment Jackevicius, A.
1993
8 5-6 p. 354-355
2 p.
artikel
62 Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1 Bruckner, A
1993
8 5-6 p. 336-
1 p.
artikel
63 Energic action with octreotide and chemotherapy in small cell lung cancer (SCLC): A pilot study Soresi, E.
1993
8 5-6 p. 357-
1 p.
artikel
64 Environmental tobacco smoke and lung cancer risk: Epidemiology in relation to confounding factors 1993
8 5-6 p. 329-
1 p.
artikel
65 Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation 1993
8 5-6 p. 334-
1 p.
artikel
66 Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic human lung tissue as detected by in situ hybridation 1993
8 5-6 p. 334-
1 p.
artikel
67 Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines 1993
8 5-6 p. 336-337
2 p.
artikel
68 Feasibility of curative radiotherapy with a simultaneous boost technique in 33 patients with non small cell lung cancer (NSCLC) Schuster-Uitterhoeve, A.L.J.
1993
8 5-6 p. 355-
1 p.
artikel
69 Fibrolaser therapy of airway malignant disease in combination with endobronchial brachyradio therapy Fis̆er, F.
1993
8 5-6 p. 355-
1 p.
artikel
70 First establishment of a human monoclonal antibody directed to sulfated glycosphingolipids S(M4s-Gal) and S(M4g), from a patient with lung cancer 1993
8 5-6 p. 337-
1 p.
artikel
71 Full staging in patients with small cell lung cancer, indispensable condition in rational management żuławski, M.
1993
8 5-6 p. 358-
1 p.
artikel
72 Growth inhibition by cholera toxin of human lung carcinoma cell lines: Correlation with G(M1) ganglioside expression Kaur, G
1993
8 5-6 p. 336-
1 p.
artikel
73 High dose endobronchial irradiation in recurrent bronchogenic carcinoma 1993
8 5-6 p. 349-
1 p.
artikel
74 High-dose radiotherapy and unconventional radiation schedules Saunders, M.I.
1993
8 5-6 p. 355-
1 p.
artikel
75 High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors 1993
8 5-6 p. 336-
1 p.
artikel
76 Imaged thoracic lobectomy: Should it be done? 1993
8 5-6 p. 345-
1 p.
artikel
77 Immunological detection of elastin-derived peptides in sera of patients with lung cancer Nicoloff, G.
1993
8 5-6 p. 360-
1 p.
artikel
78 Improved long-term survival in poor prognosis extensive-stage (ES) small cell lung cancer on CEMOV-P chemotherapy Perroni, D.
1993
8 5-6 p. 357-
1 p.
artikel
79 Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer 1993
8 5-6 p. 347-
1 p.
artikel
80 Induction chemotherapy by Mitomycin C + Ifosfamide + Cisplatin (MIP) in patients with non metastatic unresectable non small cell lung cancer (NSCLC) Giner, V.
1993
8 5-6 p. 359-
1 p.
artikel
81 Induction chemotherapy by mitomycin C + ifosfamide + cisplatin (MTP) in patients with non metastatic unresectable non small cell lung cancer (NSCLC) Baumöhl, J.
1993
8 5-6 p. 356-
1 p.
artikel
82 Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: Results of the Toronto phase II trial 1993
8 5-6 p. 346-
1 p.
artikel
83 Influence of chemotherapy on superoxide anion production by polymorphonuclear leukocytes and monocytes in patients with lung cancer 1993
8 5-6 p. 347-
1 p.
artikel
84 Intrabronchial brachytherapy using 226Radium source Kolek, V.
1993
8 5-6 p. 360-
1 p.
artikel
85 Intrathoracic organ injury associated with photodynamic therapy 1993
8 5-6 p. 350-
1 p.
artikel
86 In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs: No correlation with clinical data 1993
8 5-6 p. 345-
1 p.
artikel
87 Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture Gomi, K
1993
8 5-6 p. 338-
1 p.
artikel
88 Kinetic uptake of etanidazole in lung carcinoma and normal tissue in vivo 1993
8 5-6 p. 335-
1 p.
artikel
89 Lack of expression of p-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and from treated patients 1993
8 5-6 p. 335-
1 p.
artikel
90 Long term follow-up of nonselective set of patients with lung cancer - epidemiological study Marel, M.
1993
8 5-6 p. 357-
1 p.
artikel
91 Long term survival in small cell lung cancer: Posttreatment characteristics in patients surviving five to 18 + years Lassen, U.
1993
8 5-6 p. 359-
1 p.
artikel
92 Lung cancer detection and prevention: Evidence for an interaction between smoking and genetic predisposition 1993
8 5-6 p. 330-
1 p.
artikel
93 Lung cancer in a galvanizer an occupational disease? 1993
8 5-6 p. 330-
1 p.
artikel
94 Lung cancer in association with human immunodeficiency virus infection 1993
8 5-6 p. 342-
1 p.
artikel
95 Lung cancer in the Czech Republic: Some important epidemiological parameters Zatloukal, P.
1993
8 5-6 p. 359-
1 p.
artikel
96 Man-made mineral fibers and lung cancer: An hypothesis 1993
8 5-6 p. 327-
1 p.
artikel
97 Massive air embolism complicating Nd-YAG laser endobronchial photoresection 1993
8 5-6 p. 350-
1 p.
artikel
98 Mechanisms of collateral sensitivity to fluorouracil of a cisdiamminedichloroplatinum(II)-resistant human non-small lung cancer cell line 1993
8 5-6 p. 348-
1 p.
artikel
99 Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer 1993
8 5-6 p. 348-
1 p.
artikel
100 Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung carcinoma cells 1993
8 5-6 p. 333-
1 p.
artikel
101 Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer 1993
8 5-6 p. 339-
1 p.
artikel
102 Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma Chang, K
1993
8 5-6 p. 336-
1 p.
artikel
103 Monoclonal antibody MON-114: Detection of a marker for neuroendocrine differentiation in human lung cancer 1993
8 5-6 p. 339-
1 p.
artikel
104 Multiple primary malignant neoplasms in patients with occupational lung cancer Fatková, R.
1993
8 5-6 p. 360-
1 p.
artikel
105 Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients 1993
8 5-6 p. 333-
1 p.
artikel
106 Natural interferon alfa as maintenance therapy for small lung cancer 1993
8 5-6 p. 348-
1 p.
artikel
107 Neuroendocrine phenotype in lung cancers: Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes Brambilla, E
1993
8 5-6 p. 339-
1 p.
artikel
108 Neuron-specific enolase (NSE) in small-cell lung cancer: Longitudinal tumor marker evaluation 1993
8 5-6 p. 343-
1 p.
artikel
109 New approaches to treating early lung cancer 1993
8 5-6 p. 351-
1 p.
artikel
110 New potential chemopreventive agents for lung carcinogenesis of tobacco-specific nitrosamine 1993
8 5-6 p. 330-
1 p.
artikel
111 Nitrosamine-induced lung carcinogenesis and Ca2+/calmodulin antagonists 1993
8 5-6 p. 331-
1 p.
artikel
112 Non-small cell lung cancer cIIIa: Neoadjuvant chemotherapy + surgery + adjuvant chemotherapy or/and radiotherapy Lewinski, T.
1993
8 5-6 p. 354-
1 p.
artikel
113 Occupational and environmental hazards associated with lung cancer 1993
8 5-6 p. 328-
1 p.
artikel
114 Occupational lung cancer 1993
8 5-6 p. 332-
1 p.
artikel
115 Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations 1993
8 5-6 p. 335-
1 p.
artikel
116 Orthotopic liver transplantation for metastases of bronchial carcinoid tumor 1993
8 5-6 p. 351-
1 p.
artikel
117 Outcome of patients with lung cancer detected via mass screening as compared to those presenting with symptoms 1993
8 5-6 p. 331-
1 p.
artikel
118 Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo 1993
8 5-6 p. 339-
1 p.
artikel
119 Oxygen transport during incremental exercise load as a predictor of operative risk in lung cancer patients 1993
8 5-6 p. 344-
1 p.
artikel
120 Palliative radiotherapy in advanced metastatic and non-metastatic non-small cell lung cancer Slotman, B.J.
1993
8 5-6 p. 285-292
8 p.
artikel
121 Papillary adenoma of the lung 1993
8 5-6 p. 335-
1 p.
artikel
122 Participation of poly(ADP-ribose) polymerase in the drug sensitivity in human lung cancer cell lines 1993
8 5-6 p. 334-
1 p.
artikel
123 Passive smoking and canine lung cancer risk 1993
8 5-6 p. 327-
1 p.
artikel
124 Patient and hospital characteristics related to in-hospital mortality after lung cancer resection 1993
8 5-6 p. 344-
1 p.
artikel
125 Pattern of care and prognosis of lung cancer patients: Fifteen years experience of S. Carlo Hospital Medical Oncology Clerici, M.
1993
8 5-6 p. 358-
1 p.
artikel
126 Patterns of failure in small cell lung cancer (SCLC) Jereczek, B.
1993
8 5-6 p. 360-
1 p.
artikel
127 Peripheral biphasic adenocarcinoma of the lung: Light microscopic and immunohistochemical findings 1993
8 5-6 p. 339-
1 p.
artikel
128 Phase II study of high-dose aclarubicin in previously treated patients with small-cell lung cancer 1993
8 5-6 p. 348-
1 p.
artikel
129 Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer, Radiation Therapy Oncology Group 88-04 1993
8 5-6 p. 349-
1 p.
artikel
130 Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: A cancer and leukemia group B study 1993
8 5-6 p. 347-
1 p.
artikel
131 Plasmaphresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies Graus, F
1993
8 5-6 p. 341-
1 p.
artikel
132 Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: No correlation with adduct levels in lung 1993
8 5-6 p. 330-
1 p.
artikel
133 Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer D'Amico, D
1993
8 5-6 p. 337-
1 p.
artikel
134 Possibilities of high-dose radiotherapy and intense chemotherapy of non small-cell lung cancer Jurga, L'.
1993
8 5-6 p. 358-
1 p.
artikel
135 Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma Tisi, E
1993
8 5-6 p. 340-
1 p.
artikel
136 Primary lung tumors in mice: An experimentally maniputable model of human adenocarcinoma 1993
8 5-6 p. 338-
1 p.
artikel
137 Primary tracheal neoplasms: Recognition, diagnosis and evaluation 1993
8 5-6 p. 351-
1 p.
artikel
138 Prognostic factors for long term survival in small cell lung cancer (SCLC) Senkus, E.
1993
8 5-6 p. 359-
1 p.
artikel
139 Prognostic significance of histopathologic subtype and stage in small cell lung cancer Fraire, AE
1993
8 5-6 p. 340-
1 p.
artikel
140 Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung Carey, FA
1993
8 5-6 p. 342-
1 p.
artikel
141 Prognostic value of neuron-specific enolase in small cell lung cancer patients Szturmowicz, Monika
1993
8 5-6 p. 259-264
6 p.
artikel
142 Psychosocial issues in the treatment of patiens with lung cancer 1993
8 5-6 p. 351-
1 p.
artikel
143 Radiotherapy of non small cell lung cancers. A retrospective analysis and presentation of a new trial with unconventional fractionation Dobrowsky, W.
1993
8 5-6 p. 355-
1 p.
artikel
144 Radiotherapy or chemoradiotherapy for stage III non small cell lung cancer? (NSCLC). A review of 107 patients (pts) Juin, P.
1993
8 5-6 p. 359-
1 p.
artikel
145 Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis 1993
8 5-6 p. 350-
1 p.
artikel
146 ras Gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis Sugio, K
1993
8 5-6 p. 342-
1 p.
artikel
147 Results of whole brain radiotherapy for brain metastases of small cell lung cancer Hagedorn, Heike E.
1993
8 5-6 p. 293-300
8 p.
artikel
148 Risk of lung cancer among cigarette and pipe smokers in Southern China JH, Lubin
1993
8 5-6 p. 332-
1 p.
artikel
149 Second surgical intervention for recurrent and second primary bronchogenic carcinomas Watanabe, Y
1993
8 5-6 p. 344-
1 p.
artikel
150 Serum laminin P1 in small cell lung cancer: A valuable indicator of distant metastasis? 1993
8 5-6 p. 340-
1 p.
artikel
151 Small cell carcinoma of the lung: Treatment in the community 1993
8 5-6 p. 351-
1 p.
artikel
152 Smoking and lung cancer in China: Combined analysis of eight case-control studies 1993
8 5-6 p. 327-328
2 p.
artikel
153 Staging lung carcinoma with a Tc-99m labeled monoclonal antibody 1993
8 5-6 p. 343-
1 p.
artikel
154 1st Central European Lung Cancer Conference, Prague, September 13–15, 1992 Gregor, Anna
1993
8 5-6 p. 319-322
4 p.
artikel
155 Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer 1993
8 5-6 p. 345-346
2 p.
artikel
156 Survival and long term survival analysis in advanced non small cell lung cancer (NSCLC): The experience of the European lung cancer working party Paesmans, M.
1993
8 5-6 p. 354-
1 p.
artikel
157 Survival in patients with superior pulmonary sulcus tumors 1993
8 5-6 p. 349-
1 p.
artikel
158 Survival of patients with non-small cell lung cancer undergoing incomplete resection or exploratory thoracotomy with no resection Ichinose, Yukito
1993
8 5-6 p. 265-274
10 p.
artikel
159 Teniposide as single drug therapy for elderly patients affected by small cell lung cancer 1993
8 5-6 p. 347-
1 p.
artikel
160 The cost of treating small cell lung cancer 1993
8 5-6 p. 351-
1 p.
artikel
161 The course of the disease in our patients with SCLC treated by surgery and adjuvant chemotherapy Berzinec, P.
1993
8 5-6 p. 360-
1 p.
artikel
162 The diagnostic significance of gastrin measurement of bronchoalveolar lavage fluid for lung cancer 1993
8 5-6 p. 342-
1 p.
artikel
163 The effect of dietary intake of fruits and vegetables on the odds ratio of lung cancer among Yunnan tin miners 1993
8 5-6 p. 329-
1 p.
artikel
164 The effect of surgical treatment on survival from early lung cancer; implications for screening 1993
8 5-6 p. 344-
1 p.
artikel
165 The incidence and treatment of lung cancer in the East Slovakia Region Baumöhl, J.
1993
8 5-6 p. 359-
1 p.
artikel
166 The significance of diagnostic procedures before and after palliative endobronchial ND: YAG laser therapie to access the effectiveness and necessity for repeatedly debulking Elfeldt, R.J.
1993
8 5-6 p. 356-
1 p.
artikel
167 The use of simulator and CT information in the planning of radiotherapy for non-small cell lung cancer: An Australasian patterns of practice study Denham, J.W.
1993
8 5-6 p. 275-284
10 p.
artikel
168 The value of lipid parameters in the differential diagnosis of pleural effusions Kuşçu, B.
1993
8 5-6 p. 358-
1 p.
artikel
169 Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin 1993
8 5-6 p. 346-
1 p.
artikel
170 Trends in the association of Lambert-Eaton myasthenic syndrome with carcinoma 1993
8 5-6 p. 341-
1 p.
artikel
171 Type of tobacco and risk of lung cancer: A case-control study from Uruguay 1993
8 5-6 p. 327-
1 p.
artikel
172 Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: A potential risk marker for smoking-related diseases 1993
8 5-6 p. 331-
1 p.
artikel
173 Use of a multistage model to predict time trends in smoking induced lung cancer 1993
8 5-6 p. 329-
1 p.
artikel
174 Utility of squamous cell carcinoma antigen (SCC Ag) as a tumour marker in pulmonary malignancy 1993
8 5-6 p. 343-
1 p.
artikel
                             174 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland